comments_image Comments

Most of What You Think You Know About Milk Is Probably Dairy Industry Lies

The powerful dairy lobby has been spreading dangerous health claims about milk for decades.

Continued from previous page


Needless to say, milk is hardly a health food that the government should be promoting to children. It is linked to obesity, cholesterol and other life-long health problems. Mega dairies are also notorious for environmental, worker and animal abuse and often called "environmental crack houses."

Of course, in addition to its marketing efforts with the USDA, the dairy industry has rolled out products and supplements that help people with lactose intolerance "enjoy all the great taste of dairy and avoid the discomfort," and drink more milk. Now,  Big Pharma is joining in the dairy industry's decades-long history of recruiting more milk drinkers with specious marketing.  Big Pharma now suggests that  people can overcome their milk allergy by taking a genetically altered drug that is linked to cancers and deaths!

The drug Xolair, omalizumab, a member of an immune-suppressing class of drugs, reduced symptoms of milk allergies said researchers at the recent American Academy of Allergy, Asthma, and Immunology annual meeting. "I think the evidence is pretty strong that it does make a significant difference," said a coauthor of the research, Hugh Sampson, MD of Mount Sinai Hospital who reports eight financial links to  Big Pharma companies.

Xolair and other recombinant DNA-derived monoclonal antibody drugs like Cimzia, Enbrel, Humira and Remicade can make as much as $10,000 to $20,000 a year per patient for Big Pharma. In patients who actually need them, like those with autoimmune diseases, they are important drugs. But since the "MoAbs" debuted, it has been a race to the bottom for Big Pharma to find everyday conditions which could justify prescribing the expensive, injected drugs.

Remember how antipsychotic drugs like Seroquel, approved for schizophrenia, soon became drugs of choice for every day depression and the "blues"? That is the same marketing plan for MoAbs (called "indication creep") which are now marketed for everyday asthma, skin conditions, indigestion and now, apparently food allergies. If private and government health insurers want to fork over millions for the bio-engineered Franken drugs which are "meddling with Mother Nature," according to the  People's Pharmacy that merely loots tax dollars and raises insurance premiums. But the drugs also kill.

MoAbs cause TB, cancers and super infections according to their labels because they suppress the immune system. Xolair was investigated by the  FDA for links to heart attack and stroke and 77 people who took Xolair  had life-threatening allergic responses in a year and a half, according to FDA reports.  This is a drug to treat milk allergies?

There is also a shadow over Xolair’s clinical trials. They were  conducted at Vivra which was investigated twice by the FDA for procedural irregularities. Trials of Xolair and at least seven other drugs were corrupted by protocol violations and outright falsifications, according to a former clinical research subinvestigator who worked at the facility. San Mateo, Calif.-based Vivra Asthma & Allergy was the nation’s largest respiratory disease physician practices until a merger with Lakewood, Colo.-based Gambro in 1997 and with El Segundo, Calif.-based DaVita in 2005.

Once again Pharma has a dangerous, expensive drug that almost no one needs and is creating lame and contrived uses. And once again the dairy industry will sink as low as it needs to, to sell product. Does anyone believe someone should tamper with their immune system just to drink milk? Except, of course, Big Pharma and the dairy industry?


Martha Rosenberg is an investigative health reporter and the author of "Born With a Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp the Public Health (Random House)."

See more stories tagged with: